Ontology highlight
ABSTRACT: Potential Biomarkers of Long-term Benefit from Single-agent Trastuzumab or Lapatinib in HER2-positive Metastatic Breast Cancer
PROVIDER: PRJNA198900 | ENA |
REPOSITORIES: ENA
ACCESS DATA